article thumbnail

AGC and RoosterBio partner for cell and exosome therapy manufacturing

Pharmaceutical Technology

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. These capabilities comprise cell and exosome genetic engineering for expressing therapeutic targets.

article thumbnail

China NMPA grants approval for CanSinoBIO’s Covid-19 vaccine as booster

Pharmaceutical Technology

The company has presently attained steady manufacturing of several innovative vaccines and set up a supply chain worldwide to increase accessibility to quality vaccine products for people globally.

Vaccine 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. The enzymes must be manufactured under cGMP conditions – completely free of animal-derived ingredients.”. Developing best-in-class speciality enzymes.

Drugs 295
article thumbnail

RoosterBio and MBL Beijing Biotech team up to accelerate advanced therapy manufacturing in China

BioPharma Reporter

RoosterBio has entered into an exclusive distributor partnership with MBL Beijing Biotech: with RoosterBioâs expansion media, exosome collection media, bioreactor media and genetic engineering media to be sold and distributed by MBL Beijing and thus becoming readily accessible for the first time to MSC and exosome therapy developers in China.

article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

Chimeric antigen receptor T-cell (CAR-T) therapies are the only genetically modified cell therapies to have received regulatory approval, and they are currently utilised in relapsed/refractory settings.

article thumbnail

Kraft Heinz’s New Vegan Hot Dogs + How Precision Fermentation Could Revolutionize the Food Industry – Xtalks Food Podcast Ep. 151

XTalks

Moreover, this technology allows for the production of specific food ingredients, including those that contribute to the savory taste in dishes, sourness in soft drinks and essential enzymes in cheese manufacturing. The study also highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens.

article thumbnail

COVID prompts another milestone, as India clears first DNA vaccine

pharmaphorum

Ahmedabad-based Zydus Cadila has said it expects to launch ZyCoV-D in late September or early October, and expects to be able to manufacture around 100-120 million doses a year, with around 10 million available at launch. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.

DNA 98